Nilsson Kent R, Berenholtz Sean M, Garrett-Mayer Elizabeth, Dorman Todd, Klag Michael J, Pronovost Peter J
Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Arch Surg. 2007 Feb;142(2):126-32; discussion 133. doi: 10.1001/archsurg.142.2.126.
Perioperative allogeneic blood product transfusion would be associated with venous thromboembolic complications in surgical patients.
Observational study using a state discharge database.
Nonfederal acute care hospitals in Maryland performing colorectal cancer resections between January 1, 1994, and December 31, 2000.
We obtained data on 14 014 adult patients having a primary diagnosis code for colorectal cancer and a primary procedure code for colorectal resection.
The primary outcome variable was a discharge diagnosis of venous thromboembolism (VTE).
Venous thromboembolism occurred in 1% of patients and was associated with an adjusted 3.8-fold increase in mortality (odds ratio, 3.8; 95% confidence interval, 2.1-6.8), a 61% increase in mean hospital length of stay, and a 72% increase in mean total hospital charges. Risk factors for VTE after adjustment included transfusion, female sex, age 80 years or older, moderate to severe liver disease vs no liver disease, admission through the emergency department, and low annual surgeon case volume. Transfusion was associated with an increase in the odds of developing VTE in women (odds ratio, 1.8; 95% confidence interval, 1.2-2.6) but not in men (odds ratio, 0.9; 95% confidence interval, 0.5-1.9). In the absence of transfusion, female compared with male sex was not associated with an increased risk of VTE (odds ratio, 1.2; 95% confidence interval, 0.8-1.7).
In this large observational study of patients undergoing colorectal cancer resection, perioperative allogeneic blood transfusion was associated with an increased risk of VTE in women but not in men. Given the substantial morbidity and mortality associated with VTE and the implication that this finding has for postoperative management in women, this association must be confirmed in independent studies.
围手术期异体输血与手术患者静脉血栓栓塞并发症相关。
使用州出院数据库进行的观察性研究。
1994年1月1日至2000年12月31日期间在马里兰州进行结直肠癌切除术的非联邦急症护理医院。
我们获取了14014例成年患者的数据,这些患者的主要诊断编码为结直肠癌,主要手术编码为结直肠癌切除术。
主要结局变量为静脉血栓栓塞(VTE)的出院诊断。
1%的患者发生了静脉血栓栓塞,其与死亡率调整后增加3.8倍相关(比值比,3.8;95%置信区间,2.1 - 6.8),平均住院时间增加61%,平均总住院费用增加72%。调整后VTE的危险因素包括输血、女性、80岁及以上年龄、中度至重度肝病与无肝病、通过急诊科入院以及外科医生年手术量低。输血与女性发生VTE的几率增加相关(比值比,1.8;95%置信区间,1.2 - 2.6),但与男性无关(比值比,0.9;95%置信区间,0.5 - 1.9)。在未输血的情况下,女性与男性相比,VTE风险并未增加(比值比,1.2;95%置信区间,0.8 - 1.7)。
在这项对接受结直肠癌切除术患者的大型观察性研究中,围手术期异体输血与女性而非男性的VTE风险增加相关。鉴于VTE相关的显著发病率和死亡率以及这一发现对女性术后管理的影响,这一关联必须在独立研究中得到证实。